Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Short Percentage of Float


SHSE:688513 Chengdu Easton Biopharmaceuticals Co Ltd SHSE:688513
95 GF Score
Price ¥55.08
GF Value ¥47.90
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Chengdu Easton Biopharmaceuticals Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:688513 vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengdu Easton Biopharmaceuticals Co Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's Short Percentage of Float falls into.


SHSE:688513
95GF Score
Chengdu Easton Biopharmaceuticals Co Ltd SHSE:688513
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Overvalued in 2026?

Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co stock appears to be overvalued. The current stock price of ¥55.08 is trading 15% above its estimated GF Value™ of ¥47.90. GuruFocus considers Chengdu Easton Biopharmaceuticals Co to be Modestly Overvalued.

Key valuation signals for SHSE:688513:

  • Short Percentage of Float:
  • GF Value™: ¥47.90 vs. price of ¥55.08 (15% above fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chengdu Easton Biopharmaceuticals Co Business Description

Address No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
95GF Score

Get the complete analysis for SHSE:688513

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥55.08
Price
¥47.90
GF Value